| 臺大學術典藏 |
2021-01-05T03:34:32Z |
Dextran-coated iron oxide nanoparticle-improved therapeutic effects of human mesenchymal stem cells in a mouse model of Parkinson's disease
|
Huang D.-M.; MING YAO; Lin C.-P.; Wu S.-H.; Hsiao J.-K.; Hsu S.-C.; Chung T.-H. |
| 臺大學術典藏 |
2021-01-05T03:34:31Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
Taiwan Cooperative Oncology Group; Hsu C.; Cheng A.-L.; Chen P.-J.; Liu T.-W.; Xia N.; Yuan Q.; Lin J.; Lin S.-J.; MING YAO; Chen J.-H.; Chang C.-S.; Tsou H.-H.; Pei S.-N.; Yang H.-C. |
| 臺大學術典藏 |
2021-01-05T03:34:31Z |
Retrospective analysis of frontline treatment efficacy in elderly patients with diffuse large B-cell lymphoma
|
Tien H.-F.; MING YAO; Tang J.-L.; Chou S.-C.; Liu J.-H.; Cheng C.-L. |
| 臺大學術典藏 |
2021-01-05T03:34:31Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
Li C.-C.; Kuo Y.-Y.; Chen C.-Y.; Tang J.-L.; Tsai C.-H.; Hou H.-A.; Tien F.-M.; Lin C.-T.; MING YAO; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T03:34:30Z |
Pembrolizumab induced acute corneal toxicity after allogeneic stem cell transplantation
|
Chen W.-L.; Liu J.-H.; MING YAO; Hsiao C.-C. |
| 臺大學術典藏 |
2021-01-05T03:34:30Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Tien H.-F.; Chou W.-C.; MING YAO; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Wu S.-J.; Lin C.-T.; Lin L.-I.; Liao X.-W.; Liu C.-W.; Liu M.-C.; Tseng M.-H.; Peng Y.-L.; Tien F.-M.; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y. |
| 臺大學術典藏 |
2021-01-05T03:34:28Z |
Low-dose splenic irradiation is an alternative therapy for symptomatic splenomegaly in patients with myelofibrosis
|
Kuo S.-H.; MING YAO; Wang C.-W.; Chen Y.-H.; Huang M.-S. |
| 臺大學術典藏 |
2021-01-05T03:34:28Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Hou H.-A.; Chen C.-Y.; Chou W.-C.; Lin L.-I.; MING YAO; Liu C.-W.; Liu M.-C.; Peng Y.-L.; Tsai C.-H.; Yao C.-Y.; Tien F.-M.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Tseng M.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T03:34:28Z |
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
|
Huang S.-Y.; Hou H.-A.; Chou W.-C.; Tsai C.-H.; Lin C.-T.; Li C.-C.; MING YAO; Chen C.-H.; Liao X.-W.; Liu J.-H.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S. |
| 臺大學術典藏 |
2021-01-05T03:34:27Z |
Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan
|
Huang T.-C.; Tang J.-L.; MING YAO; Yang Y.-T.; Ko B.-S.; Yu S.-C.; Wang Y.-H. |
| 臺大學術典藏 |
2021-01-05T03:34:26Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Wang Y.-T.; Lin C.-W.; Tang J.-L.; MING YAO; Yeh K.-H.; Ma W.-L.; Yeh Y.-C.; Wang H.-P.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2020-12-09T01:11:24Z |
Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia
|
Lee, Ming-Cheng; Liu, Chieh-Yu; Jhuang, Jie-Yang; Lai, Yan-Jun; Lin, Chung-Wu; Chen, Huan-Yuan; Liu, Fu-Tong; Chou, Wen-Chien; Chen, Chien-Yuan; Tang, Jih-Luh; MING YAO; Huang, Shang-Yi; Ko, Bor-Sheng; Wu, Shang-Ju; WOEI TSAY; Tien, Hwei-Fang; Chieh-Lung Cheng; Hou, Hsin-An |
| 臺大學術典藏 |
2020-12-09T01:09:50Z |
Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults
|
Tien, Hwei-Fang; Chieh-Lung Cheng; Li, Chi-Cheng; Hou, Hsin-An; Fang, Wei-Quan; Chang, Chin-Hao; Lin, Chien-Ting; Tang, Jih-Luh; Chou, Wen-Chien; Chen, Chien-Yuan; MING YAO; Huang, Shang-Yi; Ko, Bor-Sheng; Wu, Shang-Ju; WOEI TSAY |
| 臺大學術典藏 |
2020-12-09T01:07:20Z |
Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma
|
Huang, Shang-Yi; Lin, Hsiu-Hsia; Lin, Chung-Wu; Li, Chi-Cheng; MING YAO; Tang, Jih-Luh; Hou, Hsin-An; WOEI TSAY; Chou, Sheng-Je; Chieh-Lung Cheng; Tien, Hwei-Fang |
| 臺大學術典藏 |
2020-12-09T00:55:24Z |
Reduced incidence of interstitial pneumonitis after allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation
|
Chiang, Yun; Tsai, Cheng-Hong; Kuo, Sung-Hsin; Liu, Chieh-Yu; MING YAO; Li, Chi-Cheng; Huang, Shang-Yi; Ko, Bor-Sheng; Lin, Chien-Ting; Hou, Hsin-An; Chou, Wen-Chien; Liu, Jia-Hau; Lin, Chien-Chin; Wu, Shang-Ju; Hsu, Szu-Chun; Chen, Yao-Chang; Lin, Kai-Hsin; Lin, Dong-Tsamn; Chou, Hsien-Tang; Lu, Meng-Yu; Yang, Yung-Li; Chang, Hsiu-Hao; Liu, Ming-Chih; Liao, Xiu-Wen; Wu, Jian-Kuen; Chou, Sheng-Chieh; Chieh-Lung Cheng; Chen, Chien-Yuan; WOEI TSAY; Tien, Hwei-Fang; Tang, Jih-Luh; Chen, Yu-Hsuan |
| 臺大學術典藏 |
2020-12-09T00:53:33Z |
Retrospective analysis of frontline treatment efficacy in elderly patients with diffuse large B-cell lymphoma
|
Chieh-Lung Cheng; Liu, Jia-Hau; Chou, Sheng-Chieh; MING YAO; Tang, Jih-Luh; Tien, Hwei-Fang |
| 臺大學術典藏 |
2020-12-09T00:46:09Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang, Yu-Wen; Tsai, Cheng-Hong; Lin, Chien-Chin; Tien, Feng-Ming; Chen, Yu-Wen; Lin, Hsing-Yu; MING YAO; Lin, Yun-Chu; Lin, Chien-Ting; Chieh-Lung Cheng; Tang, Jih-Luh; Chou, Wen-Chien; Hou, Hsin-An; Tien, Hwei-Fang |
| 臺大學術典藏 |
2020-12-08T03:38:43Z |
Intralymphatic Spread is a Rare Finding Associated With Poor Prognosis in Diffuse Large B-Cell Lymphoma With Extranodal Involvements
|
Chou, Sheng-Chieh; Lin, Chung-Wu; Chao, Tsu-Yi; Su, Yung-Cheng; Chieh-Lung Cheng; MING YAO; Kuo, Sung-Hsin; SHAN-CHI YU |
| 臺大學術典藏 |
2020-10-28T02:42:55Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang, Yu-Hung; JIH-LUH TANG; Lee, Sze-Hwei; CHENG-HONG TSAI; Wu, Shan-Ju; HSIN-AN HOU; TAI-CHUNG HUANG; YUAN-YEH KUO; MING YAO; Chang, Koping; CHUNG-WU LIN; Lin, Yun-Chu; Tien, Fen-Ming; Chou, Wen-Chien; HWEI-FANG TIEN; CHIEN-CHIN LIN |
| 臺大學術典藏 |
2020-10-12 |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang, Yu-Hung; Tien, Hwei-Fang; Tang, Jih-Luh; Lin, Chien-Chin; Lee, Sze-Hwei; Tsai, Cheng-Hong; Wu, Shan-Ju; Hou, Hsin-An; Huang, Tai-Chung; Kuo, Yuan-Yeh; MING YAO; Chang, Koping; Lin, Chung-Wu; Lin, Yun-Chu; Tien, Fen-Ming; Chou, Wen-Chien |
| 臺大學術典藏 |
2020 |
Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan
|
Yu-Hung Wang; SHAN-CHI YU; BOR-SHENG KO; YI-TSUNG YANG; MING YAO; JIH-LUH TANG; Tai-Chung Huang |
| 臺大學術典藏 |
2020 |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Hou H.-A.; Wu S.-J.; Tsai C.-H.; Lee S.-H.; Lin C.-C.; Wang Y.-H.; Huang T.-C.; Kuo Y.-Y.; MING YAO; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2020 |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Hou H.-A.; Chou W.-C.; Tang J.-L.; Cheng C.-L.; Lin C.-T.; Lin Y.-C.; MING YAO; Lin H.-Y.; Chen Y.-W.; Tien F.-M.; Lin C.-C.; Tsai C.-H.; Wang Y.-W.; Tien H.-F. |
| 臺大學術典藏 |
2020 |
Orbital and ocular adnexal lymphoma: a review of epidemiology and prognostic factors in Taiwan
|
Liao S.-L.; Hsieh Y.-T.; Hsu C.-R.; Chen Y.-Y.; MING YAO; Wei Y.-H. |
| 臺大學術典藏 |
2020 |
RBC-derived vesicles as a systemic delivery system of doxorubicin for lysosomal-mitochondrial axis-improved cancer therapy
|
MING YAO; Hsu S.-C.; Hsieh C.-C.; Wu S.-H.; Hsiao J.-K.; Wang S.-W.; Lin C.-P.; Huang D.-M. |
